Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

被引:29
|
作者
Marshall, Katherine L. [1 ]
Farah, Mohamed H. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
amyotrophic lateral sclerosis; axonal regeneration; dying-back axonopathy; in vitro neuromuscular junction; iPSC-derived motor neurons; microfluidic device; motor axon sprouting; AMYOTROPHIC-LATERAL-SCLEROSIS; TERMINAL SCHWANN-CELLS; PLACEBO-CONTROLLED TRIAL; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; MOTOR-NEURONS; SPINAL-CORD; MOUSE MODEL; MOLECULAR-MECHANISMS; HUNTINGTONS-DISEASE;
D O I
10.4103/1673-5374.308077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
引用
收藏
页码:1901 / 1910
页数:10
相关论文
共 50 条
  • [31] NLRC5: A Potential Target for Central Nervous System Disorders
    Zhang, Lu
    Jiao, Cui
    Liu, Lingjuan
    Wang, Aiping
    Tang, Li
    Ren, Yi
    Huang, Peng
    Xu, Jie
    Mao, Dingan
    Liu, Liqun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] The potential therapeutic role of statins in central nervous system autoimmune disorders
    O. Stüve
    S. Youssef
    S. Dunn
    A. J. Slavin
    L. Steinman
    S. S Zamvil
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 2483 - 2491
  • [33] The potential therapeutic role of statins in central nervous system autoimmune disorders
    Stüve, O
    Youssef, S
    Dunn, S
    Slavin, AJ
    Steinmann, L
    Zamvil, SS
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (11) : 2483 - 2491
  • [34] Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders
    Wild, Angela R.
    Dell'Acqua, Mark L.
    PHARMACOLOGY & THERAPEUTICS, 2018, 185 : 99 - 121
  • [35] Bridging the gap of axonal regeneration in the central nervous system: A state of the art review on central axonal regeneration
    Costa, Goncalo
    Ribeiro, Filipa F. F.
    Sebastiao, Ana M. M.
    Muir, Elizabeth M. M.
    Vaz, Sandra H. H.
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [36] Therapeutic potential of fucoidan in central nervous system disorders: A systematic review
    Yang, Jing
    Zhao, He
    Qu, Shengtao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277
  • [37] Berberine: A Plant Alkaloid with Therapeutic Potential for Central Nervous System Disorders
    Kulkarni, S. K.
    Dhir, Ashish
    PHYTOTHERAPY RESEARCH, 2010, 24 (03) : 317 - 324
  • [38] MicroRNA-124: an emerging therapeutic target in central nervous system disorders
    Zhang, Wen-Hao
    Jiang, Lian
    Li, Mei
    Liu, Jing
    EXPERIMENTAL BRAIN RESEARCH, 2023, 241 (05) : 1215 - 1226
  • [39] CORRECT AXONAL REGENERATION AFTER TARGET-CELL REMOVAL IN THE CENTRAL NERVOUS-SYSTEM OF THE LEECH
    MULLER, KJ
    SCOTT, SA
    SCIENCE, 1979, 206 (4414) : 87 - 89
  • [40] Axonal regeneration of proctolinergic neurons in the central nervous system of the locust
    Pätschke, A
    Bicker, G
    Stern, M
    DEVELOPMENTAL BRAIN RESEARCH, 2004, 150 (01): : 73 - 76